329 related articles for article (PubMed ID: 21258253)
21. [Analysis of Prognostic Factors and Clinical Characteristics for Patients with Limited Stage Small Cell Lung Cancer with Pleural Effusion].
Xu K; Wang Y; Qi J; Zhao L; Wang P
Zhongguo Fei Ai Za Zhi; 2018 Jan; 21(1):16-23. PubMed ID: 29357968
[TBL] [Abstract][Full Text] [Related]
22. A 20-year retrospective study of small-cell carcinomas in Taiwan.
Li AF; Hsu HS; Hsu CY; Li AC; Li WY; Liang WY; Chen JY
J Surg Oncol; 2010 Oct; 102(5):497-502. PubMed ID: 20872953
[TBL] [Abstract][Full Text] [Related]
23. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.
Badzio A; Kurowski K; Karnicka-Mlodkowska H; Jassem J
Eur J Cardiothorac Surg; 2004 Jul; 26(1):183-8. PubMed ID: 15200999
[TBL] [Abstract][Full Text] [Related]
24. Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trial.
Colaco R; Sheikh H; Lorigan P; Blackhall F; Hulse P; Califano R; Ashcroft L; Taylor P; Thatcher N; Faivre-Finn C
Lung Cancer; 2012 Apr; 76(1):72-7. PubMed ID: 22014897
[TBL] [Abstract][Full Text] [Related]
25. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
[TBL] [Abstract][Full Text] [Related]
26. Small-cell lung cancer: prognostic factors and changing treatment over 15 years.
Gaspar LE; McNamara EJ; Gay EG; Putnam JB; Crawford J; Herbst RS; Bonner JA
Clin Lung Cancer; 2012 Mar; 13(2):115-22. PubMed ID: 22000695
[TBL] [Abstract][Full Text] [Related]
27. Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer.
Lee SS; Kim SB; Park SI; Kim YH; Ryu JS; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Cho KJ; Kim JH
Jpn J Clin Oncol; 2007 Nov; 37(11):829-35. PubMed ID: 17951334
[TBL] [Abstract][Full Text] [Related]
28. [Advances in study on the therapy for limited-stage small cell lung cancer].
Zhang H; Liu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 38(8):857-62. PubMed ID: 23982001
[TBL] [Abstract][Full Text] [Related]
29. Impact of PET staging in limited-stage small-cell lung cancer.
Xanthopoulos EP; Corradetti MN; Mitra N; Fernandes AT; Kim M; Grover S; Christodouleas JP; Evans TL; Stevenson JP; Langer CJ; Lee TT; Pryma DA; Lin LL; Simone CB; Apisarnthanarax S; Rengan R
J Thorac Oncol; 2013 Jul; 8(7):899-905. PubMed ID: 23608814
[TBL] [Abstract][Full Text] [Related]
30. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].
Yu DP; Bai LQ; Xu SF; Han M; Wang ZT
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular comorbidities and their prognostic value in small cell lung cancer patients with chemoradiotherapy.
Liang H; Wang T; Liu D; Wang H; Ba Z; Xiao Y; Liu Y; Yuan J; Yang W
Clin Transl Oncol; 2024 Jun; 26(6):1348-1356. PubMed ID: 38103121
[TBL] [Abstract][Full Text] [Related]
32. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
33. Long-Term Survival of American Joint Committee on Cancer 8th Edition Staging Descriptors for Clinical M1a Non-Small Cell Lung Cancer.
Kumar A; Xu B; Srinivasan D; Potter AL; Raman V; Lanuti M; Yang CJ; Auchincloss HG
Chest; 2024 Mar; 165(3):725-737. PubMed ID: 37544427
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy.
Roengvoraphoj O; Eze C; Niyazi M; Li M; Hildebrandt G; Fietkau R; Belka C; Manapov F
Strahlenther Onkol; 2017 Feb; 193(2):150-155. PubMed ID: 27853828
[TBL] [Abstract][Full Text] [Related]
35. Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective response.
Fujii M; Hotta K; Takigawa N; Hisamoto A; Ichihara E; Tabata M; Tanimoto M; Kiura K
Lung Cancer; 2012 Oct; 78(1):107-11. PubMed ID: 22858447
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of small cell lung cancer patients treated with cisplatin-etoposide versus carboplatin-etoposide.
Karam I; Jiang SY; Khaira M; Lee CW; Schellenberg D
Am J Clin Oncol; 2015 Feb; 38(1):51-4. PubMed ID: 23563211
[TBL] [Abstract][Full Text] [Related]
37. The role of integrated 18F-FDG PET-CT as a staging tool for limited-stage small cell lung cancer: a retrospective study.
Sohn BS; Lee DH; Kim EK; Yoon DH; Kim HO; Ryu JS; Kim SW; Suh C
Onkologie; 2012; 35(7-8):432-8. PubMed ID: 22846975
[TBL] [Abstract][Full Text] [Related]
38. Concurrent chemoradiotherapy for limited-disease small cell lung cancer in elderly patients aged 75 years or older.
Shimizu T; Sekine I; Sumi M; Ito Y; Yamada K; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
Jpn J Clin Oncol; 2007 Mar; 37(3):181-5. PubMed ID: 17426103
[TBL] [Abstract][Full Text] [Related]
39. Accelerated hypofractionated thoracic radiotherapy in limited disease small cell lung cancer : comparison with the results of conventionally fractionated radiotherapy.
Socha J; Guzowska A; Tyc-Szczepaniak D; Wierzchowski M; Sprawka A; Szczesna A; Kepka L
J BUON; 2015; 20(1):146-57. PubMed ID: 25778310
[TBL] [Abstract][Full Text] [Related]
40. Metabolic activity on [18f]-fluorodeoxyglucose-positron emission tomography/computed tomography and glucose transporter-1 expression might predict clinical outcomes in patients with limited disease small-cell lung cancer who receive concurrent chemoradiation.
Lee J; Kim JO; Jung CK; Kim YS; Yoo IeR; Choi WH; Jeon EK; Hong SH; Chun SH; Kim SJ; Kim YK; Kang JH
Clin Lung Cancer; 2014 Mar; 15(2):e13-21. PubMed ID: 24368212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
